199 related articles for article (PubMed ID: 12208595)
1. Plasma concentrations of fibrinolytic factors in the subacute phase of myocardial infarction predict recurrent myocardial infarction or sudden cardiac death.
Soeki T; Tamura Y; Shinohara H; Sakabe K; Onose Y; Fukuda N
Int J Cardiol; 2002 Oct; 85(2-3):277-83. PubMed ID: 12208595
[TBL] [Abstract][Full Text] [Related]
2. Plasma levels of tissue plasminogen activator/plasminogen activator inhibitor-1 complex and von Willebrand factor are significant risk markers for recurrent myocardial infarction in the Stockholm Heart Epidemiology Program (SHEEP) study.
Wiman B; Andersson T; Hallqvist J; Reuterwall C; Ahlbom A; deFaire U
Arterioscler Thromb Vasc Biol; 2000 Aug; 20(8):2019-23. PubMed ID: 10938026
[TBL] [Abstract][Full Text] [Related]
3. Plasma and platelet plasminogen activator inhibitor-1 in patients with acute myocardial infarction.
Soeki T; Tamura Y; Fukuda N; Ito S
Jpn Circ J; 2000 Aug; 64(8):547-53. PubMed ID: 10952148
[TBL] [Abstract][Full Text] [Related]
4. Laboratory evaluation of fibrinolysis in patients with a history of myocardial infarction.
Chandler WL; Stratton JR
Am J Clin Pathol; 1994 Aug; 102(2):248-52. PubMed ID: 8042597
[TBL] [Abstract][Full Text] [Related]
5. Alterations in the fibrinolytic system components during acute myocardial infarction.
Ioannidou-Papayannaki E; Lefkos N; Boudonas G; Efthimiadis A; Psirropoulos D; Vogas V; Papadopoulos I; Klonizakis I
Acta Cardiol; 2000 Aug; 55(4):247-53. PubMed ID: 11041123
[TBL] [Abstract][Full Text] [Related]
6. Does long-term angiotensin converting enzyme inhibition affect the concentration of tissue-type plasminogen activator-plasminogen activator inhibitor-1 in the blood of patients with a previous myocardial infarction.
Pedersen OD; Gram J; Jeunemaitre X; Billaud E; Jespersen J
Coron Artery Dis; 1997 May; 8(5):283-91. PubMed ID: 9285181
[TBL] [Abstract][Full Text] [Related]
7. Regulation of tissue-type plasminogen activator-mediated fibrinolysis by plasminogen activator inhibitor type-1 in patients with ischaemic heart disease: possible unfavourable effect of diuretics.
Pedersen OD; Gram J; Bagger H; Keller N; Jespersen J
Coron Artery Dis; 1994 Jul; 5(7):617-23. PubMed ID: 7952424
[TBL] [Abstract][Full Text] [Related]
8. An increase of C-reactive protein is associated with enhanced activation of endogenous fibrinolysis at baseline but an impaired endothelial fibrinolytic response after venous occlusion.
Speidl WS; Zeiner A; Nikfardjam M; Geppert A; Jordanova N; Niessner A; Zorn G; Maurer G; Schreiber W; Wojta J; Huber K
J Am Coll Cardiol; 2005 Jan; 45(1):30-4. PubMed ID: 15629369
[TBL] [Abstract][Full Text] [Related]
9. Clinical and biochemical factors associated with prognosis after myocardial infarction at a young age.
Malmberg K; Båvenholm P; Hamsten A
J Am Coll Cardiol; 1994 Sep; 24(3):592-9. PubMed ID: 8077526
[TBL] [Abstract][Full Text] [Related]
10. High PAI activity with correlation to triglyceride and HDL cholesterol values in patients with coronary artery disease with no difference in survivors of myocardial infarction.
Ihnken K; Speiser W; Ruf W; Thiel W; Schlepper M; Müller-Berghaus G
Ann Hematol; 1993 Nov; 67(5):237-44. PubMed ID: 8241347
[TBL] [Abstract][Full Text] [Related]
11. Plasma TAFI and soluble CD40 ligand do not predict reperfusion following thrombolysis for acute myocardial infarction.
Cruden NL; Graham C; Harding SA; Ludlam CA; Fox KA; Newby DE
Thromb Res; 2006; 118(2):189-97. PubMed ID: 16055173
[TBL] [Abstract][Full Text] [Related]
12. Retained fibrinolytic response and no coagulation activation after acute physical exercise in middle-aged women with previous myocardial infarction.
Eriksson-Berg M; Egberg N; Eksborg S; Schenck-Gustafsson K
Thromb Res; 2002 Mar; 105(6):481-6. PubMed ID: 12091046
[TBL] [Abstract][Full Text] [Related]
13. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.
Thompson SG; Kienast J; Pyke SD; Haverkate F; van de Loo JC
N Engl J Med; 1995 Mar; 332(10):635-41. PubMed ID: 7845427
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of soluble urokinase plasminogen activator receptor to predict repeat myocardial infarction and mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous intervention.
Lyngbæk S; Marott JL; Møller DV; Christiansen M; Iversen KK; Clemmensen PM; Eugen-Olsen J; Jeppesen JL; Hansen PR
Am J Cardiol; 2012 Dec; 110(12):1756-63. PubMed ID: 22981263
[TBL] [Abstract][Full Text] [Related]
15. Serial changes in plasma concentration of plasminogen activator inhibitor-1 before and serially after thrombolytic therapy for acute myocardial infarction.
Goto S; Kawai Y; Handa S; Abe S; Takahashi E; Watanabe K; Hori S; Ikeda Y
Cardiology; 1993; 82(4):280-5. PubMed ID: 8402755
[TBL] [Abstract][Full Text] [Related]
16. Fibrinolytic parameters and insulin resistance in young survivors of myocardial infarction with heterozygous familial hypercholesterolemia.
Sebestjen M; Zegura B; Guzic-Salobir B; Keber I
Wien Klin Wochenschr; 2001 Feb; 113(3-4):113-8. PubMed ID: 11253736
[TBL] [Abstract][Full Text] [Related]
17. Fibrinolytic parameters and lipoprotein(a) in young women with myocardial infarction.
Salobir B; Sabovic M; Peternel P; Stegnar M
Angiology; 2002; 53(2):157-63. PubMed ID: 11952105
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of tissue plasminogen activator and plasminogen activator inhibitor-I levels in acute myocardial infarction.
Yamada S; Yamada R; Ishii A; Ashikawa K; Kawamitsu H; Fujita K
J Cardiol; 1996 Apr; 27(4):171-8. PubMed ID: 8642503
[TBL] [Abstract][Full Text] [Related]
19. Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 levels in acute myocardial infarction.
Ganti AK; Potti A; Yegnanarayan R
Pathophysiol Haemost Thromb; 2002; 32(2):80-4. PubMed ID: 12214153
[TBL] [Abstract][Full Text] [Related]
20. Mild hyperhomocysteinemia is associated with a decreased fibrinolytic activity in patients after ST-elevation myocardial infarction.
Speidl WS; Nikfardjam M; Niessner A; Zeiner A; Jordanova N; Zorn G; Maurer G; Schreiber W; Wojta J; Huber K
Thromb Res; 2007; 119(3):331-6. PubMed ID: 16616324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
